Adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A single center, real-world study in China.

被引：0
|
作者：
Xu, Chongrui
Tu, Hai-Yan
Sun, Yueli
Li, Yang-Si
Xu, Bingfei
Wang, Binchao
Chen, Hua-Jun
Wang, Zhen
Zhou, Qing
Yang, Jinji
Yang, Qi
Wu, Yi-Long
机构：
[1] South China Univ Technol, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Sch Med, Guangzhou, Peoples R China
[2] LinkDoc Beijing Technol Co Ltd, Beijing, Peoples R China
[3] Guangdong Prov Peoples Hosp & Guangdong Acad Med, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21081
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors
    Inomata, Minehiko
    Matsumoto, Masahiro
    Hayashi, Kana
    Seto, Zenta
    Hirai, Takahiro
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Tobe, Kazuyuki
    ANTICANCER RESEARCH, 2023, 43 (07) : 3241 - 3246
  • [22] Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study
    Calleja-Chucla, Teresa
    Gonzalez, Patricia Cordeiro
    Pradeda, Alejandro Martinez
    Pertega-Diaz, Sonia
    Margusino-Framinan, Luis
    Novoa, Silvia Antolin
    BIOMEDICINES, 2025, 13 (02)
  • [23] Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer
    Tang, Monica
    Lee, Chee K.
    Lewis, Craig R.
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert J.
    LUNG CANCER, 2022, 166 : 40 - 48
  • [24] Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting
    Rizzo, Manglio Miguel
    Bluthgen, Maria Virginia
    Recondo, Gonzalo
    Naveira, Martin
    Perfetti, Aldo
    Rizzi, Florencia
    Kuzminin, Alejandro
    Faura, Victoria
    Cerini, Matias
    Videla, Alejandro
    Silva, Carlos
    Lupinacci, Lorena
    Minatta, Nicolas
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1057 - 1064
  • [25] Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting
    Manglio Miguel Rizzo
    María Virginia Bluthgen
    Gonzalo Recondo
    Martin Naveira
    Aldo Perfetti
    Florencia Rizzi
    Alejandro Kuzminin
    Victoria Faura
    Matías Cerini
    Alejandro Videla
    Carlos Silva
    Lorena Lupinacci
    Nicolás Minatta
    International Journal of Clinical Oncology, 2021, 26 : 1057 - 1064
  • [26] Immune-Checkpoint Inhibitors-Related Colitis in Advanced Non-small Cell Lung Cancer Patients: A Real-World Analysis
    Lorenzi, M.
    Massa, D.
    Angerilli, V.
    Barberio, B.
    De Ruvo, M.
    Pretelli, G.
    Benetti, B.
    Mulargiu, C.
    Resi, M. V.
    Ferro, A.
    Dal Maso, A.
    Frega, S.
    Pasello, G.
    Guarneri, V.
    Savarino, E. V.
    Fassan, M.
    Bonanno, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S121 - S122
  • [27] Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients
    Remon, Jordi
    Mezquita, Laura
    Corral, Jesus
    Vilarino, Noelia
    Reguart, Noemi
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1516 - S1533
  • [28] Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non-Small Cell Lung Cancer (NSCLC)
    Montenegro, G. Bravo
    Serzan, M.
    Belouali, A.
    Sackstein, P.
    Chen, K.
    Rao, S.
    Veytsman, I.
    Madhavan, S.
    Liu, S.
    Kim, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S366 - S366
  • [29] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
  • [30] Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
    Matsuo, Norikazu
    Azuma, Koichi
    Murotani, Kenta
    Murata, Daiki
    Matama, Goushi
    Kawahara, Akihiko
    Kojima, Takashi
    Tokito, Takaaki
    Hoshino, Tomoaki
    THORACIC CANCER, 2023, 14 (15) : 1362 - 1367
12345